|
Is second-line anti-tuberculosis drug susceptibility testing reliable? [letter]
|
Kim, S. J.; Espinal, M. A.; Abe, C.; Bai, G. H.; Boulahbal, F.; Fattorini, L.; Gilpin, C.; Hoffner, S.; Kam, K. M.; Martin-Casabona, N.; Rigouts, L.; Vincent, V.
|
International Journal of Tuberculosis and Lung Disease |
2004
|
Letter
|
|
Characterization of rifampin resistance in pathogenic mycobacteria
|
Williams, D. L.; Waguespack, C.; Eisenach, K.; Crawford, J. R.; Portaels, F.; Salfinger, M.; Nolan, C. M.; Abe, C.; Sticht-Groh, V.; Gillis, T. P.
|
Antimicrobial Agents and Chemotherapy |
1994
|
Article
|